珈创生物 (874185.oc)

+ 收藏

现金流量表(珈创生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年年报2023年中报2023年一季报2022年年报2022年中报
上市前/上市后 上市后上市前上市前上市前上市前
报表类型 合并报表合并报表合并报表合并报表合并报表
一、经营活动产生的现金流量
 销售商品、提供劳务收到的现金(元) 116,135,872.3156,393,491.6126,082,064.43143,108,216.1572,914,103.64
 收到的税费返还(元) 2,930,861.06----
 收到其他与经营活动有关的现金(元) 4,942,171.302,832,550.602,240,970.528,168,303.982,039,710.54
 经营活动现金流入小计(元) 124,008,904.6759,226,042.2128,323,034.95151,276,520.1374,953,814.18
 购买商品、接受劳务支付的现金(元) 19,474,582.739,276,362.774,661,126.7316,569,913.677,706,072.19
 支付给职工以及为职工支付的现金(元) 47,968,785.9625,753,686.5315,331,560.8140,438,382.1021,633,486.94
 支付的各项税费(元) 5,381,595.762,302,363.47162,764.5616,555,716.788,193,561.96
 支付其他与经营活动有关的现金(元) 9,831,397.494,257,914.492,148,911.8313,619,759.395,715,783.52
 经营活动现金流出小计(元) 82,656,361.9441,590,327.2622,304,363.9387,183,771.9443,248,904.61
 经营活动产生的现金流量净额(元) 41,352,542.7317,635,714.956,018,671.0264,092,748.1931,704,909.57
二、投资活动产生的现金流量
 购建固定资产、无形资产和其他长期资产支付的现金(元) 17,963,408.5110,116,455.496,160,393.4950,874,688.8313,585,370.82
 投资支付的现金(元) 1,000,000.00----
 支付其他与投资活动有关的现金(元) 60,000,000.0060,000,000.0060,000,000.00--
 投资活动现金流出小计(元) 78,963,408.5170,116,455.4966,160,393.4950,874,688.8313,585,370.82
 投资活动产生的现金流量净额(元) -78,963,408.51-70,116,455.49-66,160,393.49-50,874,688.83-13,585,370.82
三、筹资活动产生的现金流量
 吸收投资收到的现金(元) 10,000,006.25----
 取得借款收到的现金(元) ---20,000,000.0020,000,000.00
 筹资活动现金流入小计(元) 10,000,006.25--20,000,000.0020,000,000.00
 偿还债务支付的现金(元) 20,000,000.0020,000,000.0020,000,000.0010,000,000.0010,000,000.00
 分配股利、利润或偿付利息支付的现金(元) 15,101,750.00101,750.00101,750.0020,702,666.6120,326,499.97
 支付其他与筹资活动有关的现金(元) 3,310,619.401,715,217.00709,772.852,487,221.711,147,621.71
 筹资活动现金流出小计(元) 38,412,369.4021,816,967.0020,811,522.8533,189,888.3231,474,121.68
 筹资活动产生的现金流量净额(元) -28,412,363.15-21,816,967.00-20,811,522.85-13,189,888.32-11,474,121.68
五、现金及现金等价物净增加额(元) -66,023,228.93-74,297,707.54-80,953,245.3228,171.046,645,417.07
 加:期初现金及现金等价物余额(元) 133,697,491.41133,697,491.41133,697,491.41133,669,320.37133,669,320.37
 期末现金及现金等价物余额(元) 67,674,262.4859,399,783.8752,744,246.09133,697,491.41140,314,737.44
补充资料:
 净利润(元) 46,623,896.5823,842,335.9810,840,959.8664,614,980.2235,766,621.42
 资产减值准备(元) 467,408.85----
 固定资产和投资性房地产折旧(元) 9,246,296.994,278,597.032,097,240.847,880,346.653,853,539.60
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧(元) 9,246,296.994,278,597.032,097,240.847,880,346.653,853,539.60
 无形资产摊销(元) 611,684.88305,842.44152,921.22576,484.18278,585.17
 长期待摊费用摊销(元) 2,712,139.73640,540.87320,078.071,267,685.55631,738.32
 处置固定资产、无形资产和其他长期资产的损失(元) -24,438.79-24,438.79-24,438.79-37,951.06-
 固定资产报废损失(元) 4,035.333,711.062,039.042,353.22311.91
 财务费用(元) 835,972.53394,587.20242,359.681,366,505.96635,767.79
 投资损失(元) 411,031.49146,996.91118,550.76721,951.84-204,611.11
 递延所得税(元) -282,756.23-132,978.67-146,464.821,743,643.8516,792.37
  其中:递延所得税资产减少(元) -1,084,766.4790,478.0143,131.49-121,916.2316,792.37
 递延所得税负债增加(元) 802,010.24-223,456.68-189,596.311,865,560.08-
 存货的减少(元) -1,034,003.51-3,100,635.58-1,819,523.85-1,926,308.32-565,245.17
 经营性应收项目的减少(元) -8,755,863.28-1,256,029.002,727,817.90-7,272,601.40-2,414,502.38
 经营性应付项目的增加(元) -12,922,940.41-9,133,684.64-9,215,228.51-7,603,759.74-7,554,019.56
 现金的期末余额(元) 67,674,262.4859,399,783.8752,744,246.09133,697,491.41140,314,737.44
 减:现金的期初余额(元) 133,697,491.41133,697,491.41133,697,491.41133,669,320.37133,669,320.37
 现金及现金等价物的净增加额(元) -66,023,228.93-74,297,707.54-80,953,245.3228,171.046,645,417.07
公告日期 2024-02-282023-08-302023-06-072023-06-072022-11-16
审计意见(境内) 标准无保留意见标准无保留意见标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院